Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026)
Organogenesis Holdings' (ORGO) quarterly Other Non Operating Income came in at $38000.0 in Q1 2026, up 1800.0% year-on-year from $2000.0 in Q1 2025, and down 93.82% quarter-over-quarter from $615000.0 in Q4 2025.
Organogenesis Holdings (ORGO) Other Non Operating Income (2017 - 2026) Analysis & Trends
Organogenesis Holdings' Other Non Operating Income history runs 10 years deep, the most recent figure standing at $38000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 1800.0% year-over-year to $38000.0 in Q1 2026; TTM through Mar 2026 was $744000.0, a 74500.0% increase from a year earlier, with the FY2025 full-year figure at $708000.0, up 3440.0% from the prior year.
- Other Non Operating Income eased to $38000.0 in Q1 2026 per ORGO's latest filing, from $615000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $615000.0 in Q4 2025 and bottomed at -$28000.0 in Q2 2024.
- The 5-year median for Other Non Operating Income is $18000.0 (2025), against an average of $47647.1.
- Across the five-year window, Other Non Operating Income tumbled 516.67% in 2023 and jumped 2377.78% in 2025, its largest moves.
- Year by year, Other Non Operating Income stood at $6000.0 in 2022, then tumbled by 516.67% to -$25000.0 in 2023, then dropped by 8.0% to -$27000.0 in 2024, then soared by 2377.78% to $615000.0 in 2025, then plunged by 93.82% to $38000.0 in 2026.
- Per Business Quant, the three latest ORGO Other Non Operating Income figures stand at $38000.0 (Q1 2026), $615000.0 (Q4 2025), and $18000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 310.55 Mn | 218.45 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38,000.00 |
| Dec 31, 2025 | 615,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 73,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | -27,000.00 |
| Sep 30, 2024 | 52,000.00 |
| Jun 30, 2024 | -28,000.00 |
| Mar 31, 2024 | 23,000.00 |
| Dec 31, 2023 | -25,000.00 |
| Sep 30, 2023 | 31,000.00 |
| Jun 30, 2023 | 28,000.00 |
| Mar 31, 2023 | 23,000.00 |
| Dec 31, 2022 | 6,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | -21,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Sep 30, 2021 | -19,000.00 |
| Jun 30, 2021 | 18,000.00 |
| Mar 31, 2021 | -3,000.00 |